HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $22 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 92.6%

Neg 0% Neu 92.6% Pos 0%

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price target.